Illumina, Inc. develops, manufactures, and markets life science tools and integrated systems for the analysis of genetic variation and function in North America, Europe, Latin America, the Asia-Pacific, the Middle East, and South Africa. The companys products include sequencing platforms that are based on its SBS technology are designed to meet the various demands of a range of sequencing applications; and array platforms consist of HiScan and iScan systems that are array scanners, which support the imaging of array-based genetic analysis products. It also offers various sample preparation and sequencing kits to simplify workflows and accelerate analysis. In addition, the company provides genotyping and whole genome sequencing services. It serves genomic research centers, academic institutions, government laboratories, hospitals, and reference laboratories, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic, and consumer genomics companies. The company sells its products directly, as well as through distributors. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.
Illumina (ILMN) Tops Q2 Earnings & Revenues, Ups Guidance - Analyst Blog24 Jul 2014, 10:58 amIllumina (ILMN) Tops Q2 Earnings & Revenues, Ups Guidance - Analyst Blog
Illumina (ILMN) Tops Q2 Earnings & Revenues, Ups Guidance24 Jul 2014, 9:00 amIllumina (ILMN) reported adjusted earnings of 57 cents per share in the second quarter of 2014, beating the Zacks Consensus Estimate by 6 cents or 11.8%
Illumina Q2 Profit Up 30%, Results Beat View, Lifts 2014 Outlook23 Jul 2014, 10:02 pmBiotechnology company Illumina Inc. (ILMN) on Wednesday reported a 30 percent increase in profit for the second quarter from last year on double-digit revenue growth.
Illumina Reports Strong Financial Results for Second Quarter of Fiscal Year 201423 Jul 2014, 2:05 pmIllumina, Inc. today announced its financial results for the second quarter of 2014.
After-Hours Earnings Report for July 23, 2014 : T, FB, QCOM, GILD, CCI, ILMN, AVB, WFT, NXPI, ORLY, TRIP, CA23 Jul 2014, 12:09 pmAfter-Hours Earnings Report for July 23, 2014 : T, FB, QCOM, GILD, CCI, ILMN, AVB, WFT, NXPI, ORLY, TRIP, CA
Earnings Watch For July 23 (BA, PEP, TUP, WHR, FB, T, QCOM)23 Jul 2014, 3:17 amDefense and aerospace giant Boeing Co. (BA) is scheduled to post second quarter results before the markets open. The earnings of the company are expected to grow to $2.01 per share from $1.67 per share reported a year earlier, while revenues are anticipated to increase to $22.23 billion from last year's $21.82 billion. The shares of BA closed Tuesday's trade at $129.74. (52-wk H/L $144.57/$101.77)
Weekly CFO Sells Highlight: Envision Healthcare Holdings Inc, Google Inc, Illumina Inc.20 Jul 2014, 10:21 amBy Myra Ramdenbourg. Read more » » Related Stocks: EVHC , GOOG , ILMN ,
Critical Alerts For Illumina, T Rowe Price, Dow Chemical, MGM Resorts, and Du Pont Released By InvestorsObserver7 Jul 2014, 7:43 amCHICAGO, July 7, 2014 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for ILMN, TROW, DOW, MGM, and DD. To see what our analysts have discovered about a particular stock, read the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. (Note:...
Illumina Expands in Europe on 3 NIPT Deals1 Jul 2014, 3:05 pmIllumina Inc. (ILMN) has entered into three separate partnership agreements with Biomnis, Genoma, and the Center for Human Genetics and Laboratory Diagnostics Martinsrieduse.
Illumina Inc. (ILMN) Is Approaching The Highs Of The Year30 Jun 2014, 8:31 amIllumina Inc. (ILMN) has been rising for the majority of early trade Monday and is currently higher by 4.43 at $177.13.